Phase II Study of Paclitaxel, Cisplatin, and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer

This phase II study evaluated the efficacy and safety of combination chemotherapy with paclitaxel, cisplatin, and 5-fluorouracil (5-FU) in advanced gastric cancer. Patients with histologically confirmed gastric adenocarcinoma were eligible for the study. Paclitaxel (175 mg/m(2)) and cisplatin (75 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Junyl, Cho, Sang-Hee, Shim, Hyun Jeong, Lee, Se-Ryeon, Ahn, Jae Sook, Yang, Duk-Hwan, Kim, Yeo-Kyeoung, Lee, Je-Jung, Kim, Hyeoung-Joon, Chung, Ik-Joo
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526391/
https://www.ncbi.nlm.nih.gov/pubmed/18756042
http://dx.doi.org/10.3346/jkms.2008.23.4.586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526391/
https://www.ncbi.nlm.nih.gov/pubmed/18756042
http://dx.doi.org/10.3346/jkms.2008.23.4.586

Ejemplares similares